SATL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.73194791841524E-14 |
Normal-vs-Stage2 |
5.92040000357841E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
7.257600E-01 |
Stage1-vs-Stage3 |
1.34539999996353E-06 |
Stage1-vs-Stage4 |
1.217480E-04 |
Stage2-vs-Stage3 |
1.812040E-02 |
Stage2-vs-Stage4 |
3.354000E-02 |
Stage3-vs-Stage4 |
8.502200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
6.90330015373775E-11 |
Normal-vs-Asian |
2.384900E-04 |
Caucasian-vs-AfricanAmerican |
8.402800E-01 |
Caucasian-vs-Asian |
5.420400E-01 |
AfricanAmerican-vs-Asian |
6.250600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.62525548574877E-12 |
Male-vs-Female |
1.138610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.66800000478418E-08 |
Normal-vs-Age(41-60Yrs) |
1.62592161956354E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.57999999750302E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.505400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.998000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.563200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.066400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.837620E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.671600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.438400E-03 |
Normal-vs-Grade 2 |
5.38347144640738E-13 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
4.223800E-01 |
Grade 1-vs-Grade 3 |
3.057600E-02 |
Grade 1-vs-Grade 4 |
1.377310E-04 |
Grade 2-vs-Grade 3 |
2.014100E-04 |
Grade 2-vs-Grade 4 |
2.45489994998849E-09 |
Grade 3-vs-Grade 4 |
1.003300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.74988970167578E-12 |
Normal-vs-ccB subtype |
1.62536650805123E-12 |
ccA subtype-vs-ccB subtype |
9.012800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62492241884138E-12 |
Normal-vs-N1 |
2.32279973033656E-10 |
N0-vs-N1 |
4.019100E-03 |
|
|